S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
OTCMKTS:KHRNF

Khiron Life Sciences (KHRNF) Stock Forecast, Price & News

$0.01
0.00 (-14.63%)
(As of 10/2/2023 ET)
Compare
Today's Range
$0.0105
$0.0120
50-Day Range
$0.0104
$0.0170
52-Week Range
$0.01
$0.13
Volume
59,587 shs
Average Volume
199,073 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KHRNF stock logo

About Khiron Life Sciences (OTCMKTS:KHRNF) Stock

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

KHRNF Price History

KHRNF Stock News Headlines

The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
KHRNF - Khiron Life Sciences Corp.
KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER
Khiron Completes First Phase of Business Optimization
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
KHIRON LIFE SCIENCES ANNOUNCES NEW CFO
KHRNF Khiron Life Sciences Corp.
Khiron Closes Additional Loan with Investment-Grade Bank
See More Headlines
Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

KHRNF Company Calendar

Today
10/03/2023
Next Earnings (Estimated)
11/28/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:KHRNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Alvaro Francisco Torres (Age 44)
    Co-Founder, CEO & Director
    Comp: $201.6k
  • Ms. Franziska Katterbach
    Pres of Khiron Europe
  • Mr. Swapan Kakumanu ACA (Age 53)
    ACWA, CGA, Corp. Sec.
    Comp: $44.32k
  • Mr. Michael John O'Connor MA (Age 56)
    Chief Financial Officer
  • Mr. Manuel Buendia
    VP of Operations
  • Mr. Marco Algorta
    Country Mang. of Uruguay













KHRNF Stock - Frequently Asked Questions

Should I buy or sell Khiron Life Sciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares.
View KHRNF analyst ratings
or view top-rated stocks.

How have KHRNF shares performed in 2023?

Khiron Life Sciences' stock was trading at $0.0415 on January 1st, 2023. Since then, KHRNF stock has decreased by 74.7% and is now trading at $0.0105.
View the best growth stocks for 2023 here
.

Are investors shorting Khiron Life Sciences?

Khiron Life Sciences saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 146,000 shares, a decline of 9.8% from the August 31st total of 161,900 shares. Based on an average trading volume of 336,300 shares, the days-to-cover ratio is currently 0.4 days.
View Khiron Life Sciences' Short Interest
.

When is Khiron Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 28th 2023.
View our KHRNF earnings forecast
.

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.01.

How can I contact Khiron Life Sciences?

Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564.

This page (OTCMKTS:KHRNF) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -